When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VIR - Vir inks deal with Xencor for antibody-extending technology
Vir Biotechnology Inc.
Vir Biotechnology (NASDAQ:VIR) has in-licensed non-exclusive rights to Xencor's (NASDAQ:XNCR) Xtend Fc technology aimed at extending the half-lives of novel antibodies it is investigating for the potential treatment of COVID-19.
More news on: Vir Biotechnology, Inc., Xencor, Inc., Healthcare stocks news,